CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 281 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,161,019 | +154.7% | 29,550 | +195.5% | 0.01% | +233.3% |
Q4 2021 | $455,800 | -82.4% | 10,000 | -86.2% | 0.00% | -84.2% |
Q3 2021 | $2,591,150 | +144.0% | 72,500 | +47.9% | 0.02% | +58.3% |
Q3 2020 | $1,062,000 | +951.5% | 49,024 | +205.8% | 0.01% | +1100.0% |
Q4 2018 | $101,000 | -8.2% | 16,030 | +43.1% | 0.00% | 0.0% |
Q3 2018 | $110,000 | +266.7% | 11,200 | +153.6% | 0.00% | – |
Q2 2015 | $30,000 | -91.4% | 4,417 | -88.0% | 0.00% | -100.0% |
Q1 2014 | $349,000 | – | 36,692 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |